Sleep-related breathing disorder (central sleep apnoea) improved coincidentally by medical therapy with fumarates (dimethyl fumarate)

Abdulmajeed M Albadi, Mana M Alshahrani, Riyad O Allehebi

Article Type

Case Report

Published

In this article, the authors describe a case study of a 31-year-old woman known to have multiple sclerosis and concomitant severe central sleep apnoea (CSA). She received the medication dimethyl fumarate for the treatment of multiple sclerosis, and her CSA significantly improved to mild CSA after the treatment.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.